SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical
Idenix Pharmaceuticals (IDIX)
An SI Board Since March 2004
Posts SubjectMarks Bans Symbol
412 15 0 IDIX
Emcee:  michael_f_murphy Type:  Unmoderated
Introduction Market Data Compact
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
ReplyMessage PreviewFromRecsPosted
337Did a first blush look, and didn't find anything particularly complementary scaram(o)uche-4/16/2009
336<i>A route out for 899??</i> Glaxo and Pfizer create new HIV drug cscaram(o)uche-4/16/2009
335Thanks, Jim. Inasmuch as IDIX has given guidance of roughly $4M in 2009 from TyzDewDiligence_on_SI-3/16/2009
334Just in case anyone was wondering where Tyzeka rx have gone in the past 9 monthsrkrw-3/16/2009
333GSK Renews HIV Pipeline: siliconinvestor.com Comments with respect to the unanDewDiligence_on_SI-2/15/2009
332:-)DewDiligence_on_SI-2/10/2009
331Exactly why I didn't post it at ihub...idos-2/10/2009
330LOL—it sounds like Feuerstein is getting his input from iHub. This is what I posDewDiligence_on_SI-2/9/2009
329<b>Did Ardea's HIV Drug Catch the Bouquet?</b> thestreet.com Aidos-2/9/2009
328IDIX 'ReadMeFirst' updated for partnership with GSK: siliconinvestor.coDewDiligence_on_SI-2/6/2009
327IDIX Inks HIV Partnership With GSK: $34M Up-Front, $416M in Potential MilestonesDewDiligence_on_SI-2/6/2009
326<i>ReadMeFirst</i> updated: Notes from the JPM conference; HIV peneDewDiligence_on_SI-1/27/2009
325IDIX ‘ReadMeFirst’ updated: <i>IDX184 begins phase-1/2 monotherapy trial DewDiligence_on_SI-1/12/2009
324IDIX <i>ReadMeFirst</i> updated for major rewrite on HCV competitiveDewDiligence_on_SI-12/21/2008
323very useful ... thnx..mlkr-12/12/2008
322IDIX <i>ReadMeFirst</i> updated: Revealing tidbits from RDEA’s PJ wDewDiligence_on_SI-12/3/2008
321IDIX <i>ReadMeFirst</i> updated: siliconinvestor.com Updates: linkDewDiligence_on_SI-11/23/2008
320IDIX <i> ReadMeFirst</i> Updated <i>Updates: 3Q08 financial rDewDiligence_on_SI-10/31/2008
319IDIX <i>ReadMeFirst</i> updated re shareholdings of insiders/major hDewDiligence_on_SI-9/17/2008
318This venue is oddly lonely considering that: 1. IDIX is a bona fide <i>drDewDiligence_on_SI-9/4/2008
317IDIX ‘ReadMeFirst’ Updated <i>[Updates: 2008-2009 clinical goals; 100mg mDewDiligence_on_SI-9/4/2008
316<b>IDIX Drug Portfolio</b> [graphic] <i>What’s changed relatDewDiligence_on_SI-9/4/2008
315Non-Nucleoside HIV Drugs Show Promise in Early Trials: siliconinvestor.comDewDiligence_on_SI-8/11/2008
314IDIX <i>ReadMeFirst</i> updated for IDX184 news flow and clinical daDewDiligence_on_SI-8/10/2008
313IDIX <i>ReadMeFirst</i> updated for 2Q08 CC and latest on HCV prograDewDiligence_on_SI-7/29/2008
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2026 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News